ONE in every 20 adults who contract a common but little-known virus will end up in hospital, a new study reveals. Respiratory ...

The UVAX-1107 protein nanoparticle vaccine was safe and well-tolerated in healthy volunteers at the planned Interim Analysis #1 ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

RSV is associated with a considerable burden of hospitalizations, intensive care unit admissions, and in-hospital deaths among adults.

From the editorial: "Too many of us ... (are) allowing those who aim to deceive, often with ulterior motives that have ...

The Centers for Disease Control and Prevention (CDC) recommends that adults 60 years of age and older may receive a single dose of RSV vaccine, based on a discussion between a healthcare provider and ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the ...

HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share ...

Planning to gather for Thanksgiving with family and friends? Both the Green Bay Packers and Detroit Lions are playing that day, so there’s an extra incentive to settle down with a crowd post-meal to ...

When families and friends congregate in small spaces, they will be bringing whatever variants of flu, COVID and other viruses with them.

Respiratory illnesses become more common in the fall and winter months, and officials say whopping cough and pneumonia in particular are on the rise.